Detalles de la búsqueda
1.
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
BMC Cancer
; 23(1): 679, 2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468859
2.
Quality of life for older patients with cancer: a review of the evidence supporting melatonin use.
Aging Clin Exp Res
; 32(12): 2459-2468, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236899
3.
Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity.
Oncology
; 96(5): 223-234, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30943496
4.
A Retrospective Study on the Onset of Menopause after Chemotherapy: Analysis of Data Extracted from the Jean Perrin Comprehensive Cancer Center Database Concerning 345 Young Breast Cancer Patients Diagnosed between 1994 and 2012.
Oncology
; 92(5): 255-263, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28171863
5.
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
Oncology
; 90(2): 69-78, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26771576
6.
Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer.
Oncologist
; 20(3): 243-4, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25637380
7.
Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.
Oncology
; 88(5): 261-72, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25573741
8.
Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy.
Oncology
; 88(3): 180-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472499
9.
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.
Oncology
; 89(6): 319-31, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26457979
10.
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.
Front Oncol
; 11: 653370, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34249690
11.
Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients.
Front Oncol
; 11: 678315, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34367964
12.
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer.
Cancer Med
; 10(7): 2332-2340, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33666378
13.
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies.
NPJ Breast Cancer
; 7(1): 124, 2021 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34535679
14.
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?
Cancer Invest
; 28(2): 195-200, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19968496
15.
Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.
Oncology
; 78(3-4): 205-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20424491
16.
Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.
BMC Cancer
; 10: 648, 2010 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21108799
17.
PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer.
Medicine (Baltimore)
; 99(50): e23418, 2020 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33327268
18.
Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?
Cancer Invest
; 27(1): 81-5, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19191099
19.
Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
Clin Breast Cancer
; 19(1): e74-e84, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30448088
20.
Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
Oncologist
; 13(12): 1235-45, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19091781